Evaluating Insulin Delivery Systems Using Dynamic Glucose Region Plots and Risk Space Analysis
- PMID: 40807953
- PMCID: PMC12349224
- DOI: 10.3390/s25154788
Evaluating Insulin Delivery Systems Using Dynamic Glucose Region Plots and Risk Space Analysis
Abstract
Simultaneous values of glucose rate of change (RoC) and glucose can be presented in a dynamic glucose region plot, and risk spaces can be specified for (RoC, glucose) values expected to remain in the target range (glucose 3.9-10.0 mmol/L) or leave or return to the target range within the next 30 min. We downloaded continuous glucose monitoring (CGM) data for 60 days from persons with type 1 diabetes using two different systems for automated insulin delivery (AID), A (n = 65) or B (n = 85). The relative distribution of (RoC, glucose) values in risk spaces was compared. The fraction of all (RoC, glucose) values anticipated to remain in the target range in the next 30 min was higher with system A (62.5%) than with system B (56.8%) (difference 5.7, 95% CI (2.2-9.2%), p = 0.002). The fraction of (RoC, glucose) values in the target range with a risk of progressing to the above range (glucose > 10.0 mmol/L) was slightly lower in system A than in B (difference -1.1 (95% CI: -1.8--0.5%, p < 0.001). Dynamic glucose region plots and the concept of risk spaces are novel strategies to obtain insight into glucose homeostasis and to demonstrate clinically relevant differences comparing two AID systems.
Keywords: automated insulin delivery; continuous glucose monitoring; dynamic glucose region plots; glucose rate of change; risk space analysis; type 1 diabetes.
Conflict of interest statement
KWH has received research grants for an investigator-initiated study from Abbott Diabetes Care and Novo Nordisk.
Figures
References
-
- Tornese G., Carletti C., Giangreco M., Nistico D., Faleschini E., Barbi E. Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System. Diabetes Care. 2022;45:1486–1488. doi: 10.2337/dc21-2643. - DOI - PMC - PubMed
-
- Sherr J.L., Heinemann L., Fleming G.A., Bergenstal R.M., Bruttomesso D., Hanaire H., Holl R.W., Petrie J.R., Peters A.L., Evans M. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. 2022;45:3058–3074. doi: 10.2337/dci22-0018. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
